Reuters logo
BRIEF-Aclaris Therapeutics reports notice of allowance for 2 U.S. patent applications
April 4, 2017 / 12:32 PM / 8 months ago

BRIEF-Aclaris Therapeutics reports notice of allowance for 2 U.S. patent applications

April 4 (Reuters) - Aclaris Therapeutics Inc:

* Aclaris Therapeutics announces notice of allowance for two U.S. Patent applications covering baricitnib and decernotinib, respectively, for hair loss disorders

* Aclaris Therapeutics Inc - newly allowed patent applications are owned by trustees of Columbia University in city of New York and exclusively licensed to co Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below